Vall d’Hebrón University Hospital
Barcelona, Spain
Teresa Macarulla, MD, PhD, received her medical degree from the Universitat Autònoma de Barcelona in Barcelona, Spain. Afterwards, she completed her specialist training in medical oncology and has had appointments in Barcelona.
Dr Macarulla is currently a physician in the Medical Oncology Department at the Vall d’Hebron University Hospital in Barcelona, Spain. Dr Macarulla is also the head of the GI Cancer Program Unit since April 2017. She is working in the gastrointestinal tumors team. She is involved in translational research and pharmacodynamic phase I studies with molecular targeted therapies and related translational research, with a special focus on EGFR inhibitors. She is also involved in phase II and III studies with new chemotherapy agents in gastrointestinal tumors, with special interest in hepatobiliopancreatic tumors.
Dr Macarulla is the author of numerous publications, many focusing on hepatobiliopancreatic tumors and new drugs, and she has authored communications at different conferences. She actively participates in the development of national and international clinical investigations, especially in relation to drugs directed against molecular targets, as well as clinical investigations for new chemotherapy agents. Dr Macarulla is also an ad hoc reviewer for various oncology journals.
In addition, Dr Macarulla is an active member of the Spanish Society of Medical Oncology, European Society for Medical Oncology, and American Society of Clinical Oncology.
Debate: Resectable Pancreatic Cancer: Neoadjuvant Chemotherapy in All Patients? - PRO
Wednesday, June 28, 2023
14:45 – 14:55 CEST
Debate: Resectable Pancreatic Cancer: Neoadjuvant Chemotherapy in All Patients? - DISCUSSION
Wednesday, June 28, 2023
15:05 – 15:15 CEST
Session III: Cancer of the Biliary Tract
Wednesday, June 28, 2023
17:35 – 18:55 CEST
Discussant: SO-2, SO-3, SO-4, SO-5
Thursday, June 29, 2023
08:40 – 08:50 CEST
Poster Discussion Guided Tours - Group 4: Pancreatic Cancer (PD-10, PD-11, PD-12)
Thursday, June 29, 2023
17:15 – 17:35 CEST